Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Immunocore CFO And Head Of Strategy, Brian Di Donato, Informs His Plans To Leave At Year-End; Company To Initiate Search For New CFO

Author: Benzinga Newsdesk | August 29, 2024 07:19am

Di Donato has accepted the role of Chief Executive Officer at a private, early-stage biotech headquartered in San Diego, California.

Immunocore will initiate a search for a new CFO. Brian will remain as the Company's CFO and Head of Strategy through the end of 2024, to ensure a smooth transition.

Posted In: IMCR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist